These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8941644)

  • 1. Rapamycin inhibits vascular smooth muscle cell migration.
    Poon M; Marx SO; Gallo R; Badimon JJ; Taubman MB; Marks AR
    J Clin Invest; 1996 Nov; 98(10):2277-83. PubMed ID: 8941644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
    Marx SO; Jayaraman T; Go LO; Marks AR
    Circ Res; 1995 Mar; 76(3):412-7. PubMed ID: 7532117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin resistance in ataxia-telangiectasia.
    Beamish H; Williams R; Chen P; Khanna KK; Hobson K; Watters D; Shiloh Y; Lavin M
    Oncogene; 1996 Sep; 13(5):963-70. PubMed ID: 8806686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
    Sharkey J; Butcher SP
    Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular calcium transients are necessary for platelet-derived growth factor but not extracellular matrix protein-induced vascular smooth muscle cell migration.
    Hollenbeck ST; Nelson PR; Yamamura S; Faries PL; Liu B; Kent KC
    J Vasc Surg; 2004 Aug; 40(2):351-8. PubMed ID: 15297833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Schrepfer S; Deuse T; Sultan KR; Haddad M; Böger R; Münzel T; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    Cardiology; 2007; 108(2):128-37. PubMed ID: 17028423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.
    Bornfeldt KE; Raines EW; Nakano T; Graves LM; Krebs EG; Ross R
    J Clin Invest; 1994 Mar; 93(3):1266-74. PubMed ID: 8132765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
    Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
    Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-channel activity of the Ca2+-dependent K+ channel is modulated by FK506 and rapamycin.
    Terashima A; Nakai M; Hashimoto T; Kawamata T; Taniguchi T; Yasuda M; Maeda K; Tanaka C
    Brain Res; 1998 Mar; 786(1-2):255-8. PubMed ID: 9555045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12.
    Ahern GP; Junankar PR; Dulhunty AF
    Biophys J; 1997 Jan; 72(1):146-62. PubMed ID: 8994600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 13. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males.
    Dai-Do D; Espinosa E; Liu G; Rabelink TJ; Julmy F; Yang Z; Mahler F; Lüscher TF
    Cardiovasc Res; 1996 Nov; 32(5):980-5. PubMed ID: 8944830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506.
    Cao W; Mohacsi P; Shorthouse R; Pratt R; Morris RE
    Transplantation; 1995 Feb; 59(3):390-5. PubMed ID: 7532879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells.
    Ollivier V; Hammal S; Ameziane N; Labro MT; de Prost D
    Thromb Haemost; 2005 Jul; 94(1):46-52. PubMed ID: 16113783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.
    Dilling MB; Dias P; Shapiro DN; Germain GS; Johnson RK; Houghton PJ
    Cancer Res; 1994 Feb; 54(4):903-7. PubMed ID: 7508822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
    Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
    Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
    Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
    Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
    J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.